National Institutes of Health Grant: Investigating Incretin Mimetics’ Influence on Cancer Risk Mechanisms
SynopsisVersion HistoryRelated DocumentsPackage This grant, offered by the National Institutes of Health, aims to support critical studies investigating the complex mechanisms through which incretin mimetics—including GLP-1, GIP-1, or dual agents—impact cancer risk. The funding announcement seeks to promote both preclinical and patient-based research, attracting talented scientists to delve into the dynamic, long-term effects of these agents on cancer development. Current data suggests these compounds might concurrently elevate the risk for some [...]